REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N1 G.Orla (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N1 G.Orla Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

MUP Apteka N1 G.Orla is an enterprise based in Russia. Its main office is in Orel. It operates in the Pharmacies and Drug Stores sector. The company was established on February 22, 2018. The latest financial highlights indicate a net sales revenue increase of 1.88% in 2023. There was a total growth of 0.53% in MUP Apteka N1 G.Orla’s total assets over the same period. The net profit margin of MUP Apteka N1 G.Orla decreased by 0.22% in 2023.

Headquarters
Gostinaya, 3
Orel; Oryol Oblast; Postal Code: 302001

Contact Details: Purchase the MUP Apteka N1 G.Orla report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Apteka N1 G.Orla report to view the information.
Registered Capital:
Purchase the MUP Apteka N1 G.Orla report to view the information.
Incorporation Date:
February 22, 2018
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Gorodskoe Aptechnoe Spravochnoe Byuro
Company Performance
Financial values in the chart are available after MUP Apteka N1 G.Orla report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
1.88%
Total operating revenue
1.88%
Operating profit (EBIT)
18.59%
Net Profit (Loss) for the Period
-43.35%
Total assets
0.53%
Total equity
2.28%
Operating Profit Margin (ROS)
0.41%
Net Profit Margin
-0.22%
Return on Equity (ROE)
-8.92%
Quick Ratio
0.02%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?